Please login to the form below
eczema drug
This page shows the latest eczema drug news and features for those working in and with pharma, biotech and healthcare.
Lilly expands dermatology portfolio with $1.1bn Dermira deal
Deal includes FDA fast-tracked eczema drug. Eli Lilly has kicked off the new year with a $1.1bn takeover of dermatology specialist Dermira, setting the pace for pharma M&A ... the treatment of moderate-to-severe atopic dermatitis (the most common from of
Latest news
-
MorphoSys drops Novartis-partnered drug in eczema after phase 2 miss
atopic dermatitis – also known as eczema – suggested there was little chance of a positive outcome. ... Atopic dermatitis is the most common form of eczema and can affect males and females of all ages, but often starts in childhood.
-
GSK sells eczema and psoriasis drug to Dermavant for £250m
Psoriasis and atopic dermatitis (eczema) candidate tapinarof is being transferred to Roivant Sciences group company Dermavant in return for £150m upfront and another £100m in the offing if it meets development ... In phase II trials the drug had a
-
Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more
The company's ELOQUENT-3 trial combined the drug with pomalidomide and low-dose dexamethasone (EPd) in patients with relapsed/refractory multiple myeloma (RRMM). ... UK MARKET ACCESS. NICE decides on Dupixent and Opdivo. England’s cost effectiveness
-
Sanofi, Regeneron claim EU approval for eczema drug Dupixent
The EU approval is for the treatment of moderate-to severe atopic dermatitis (also known as eczema), a chronic skin condition characterised by skin blistering, cracking and often debilitating itching, and ... comes after the CHMP recommended the drug for
-
CHMP backs two rare disease therapies at April meeting
There is no approved drug to treat the underlying disease process and treatment efforts currently rely on managing symptoms. ... trial. Sanofi has just picked up an FDA approval for eczema drug Dupixent (dupilumab) - which is made at the same facility as
More from news
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
Havas Lynx Group lifts a silver Cannes Lion with landmark HIV campaign
experiential lift experience that not only stood out but also highlighted the injection as the first drug to treat severe eczema underneath the skin. ... The first ever 4D lift experience took people on an incredible journey below the skin to see how
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Biogen and Happify Health team up to create digital platform for MS patients
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Moderna to launch Innovation and Technology Center in the UK
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- How pharma found its voice – health communications for a brave new world
- The importance of beliefs in creative health engagement
- In recognition of the Anniversary of Stonewall, Nucleus Global brings attention and awareness to persistent health care inequities experienced by LGBTQIA+
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Almirall shares positive topline results from atopic dermatitis trials
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Pfizer to buy 8.1% stake in Valneva in support of joint Lyme disease programme
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
PMHub
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to...
Latest intelligence
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
- Report: Omnichannel advice for the life science industry
- In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...
